Drawing for VACU-PT

USPTO serial 74253243

VACU-PT

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
Examiner
LEVINE, HOWARD B
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VACU-PT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010diagnostic direct draw prothrombin time test apparatus; namely, a test tube containing freeze-dried thromboplastin, calcium salts, stabilizers and buffers used for blood testingABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 16, 1993ABN5ABANDONMENT - AFTER PUBLICATION
Nov 10, 1992PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 9, 1992NPUBNOTICE OF PUBLICATION
Aug 14, 1992CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 4, 1992CNEAEXAMINER'S AMENDMENT MAILED
Jun 26, 1992CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 22, 1992CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Frequently asked questions

Related guidance